Abstract
Mast cells (MCs) are secretory cells that are central players in human allergic disease and immune responses. With the exception of a few pathological situations, MCs are usually present at relatively low frequencies in most tissues. Since their first description, MCs in tissues were identified mostly using their morphological characteristics and their typical coloration when stained with aniline dyes. However, increasing availability of highly specific antibodies now permits the use of fluorescence-based flow cytometry as the method of choice for the quantification, characterization, and purification of cells in suspension. This technique allows for a rapid analysis of thousands of events and for the identification of cells present at frequencies as low as one event in 106 unwanted cells. This method also permits for simultaneous characterization of multiple antigens at a single cell level, which is ideal in order to study rare populations of cells like MCs. Here we describe the basis of flow cytometry-based immunophenotyping applied to the study of MC. The protocol focuses on the study of human MCs present in body fluids (mainly bone marrow) but can easily be adapted to studying MCs from other tissues and species.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ishizuka T, Okajima F, Ishiwara M et al (2001) Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase. J Immunol 167:2298–2304
Kitaura J, Kinoshita T, Matsumoto M et al (2005) IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood 105:3222–3229
Moon TC, St Laurent CD, Morris KE et al (2010) Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 3:111–128
Kitamura Y, Ito A (2005) Mast cell-committed progenitors. Proc Natl Acad Sci U S A 102:11129–11130
Shimizu Y, Sakai K, Miura T et al (2002) Characterization of “adult-type” mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymase, and CD13 expression is reduced during differentiation. Clin Exp Allergy 32:872–880
Austen KF, Boyce JA (2001) Mast cell lineage development and phenotypic regulation. Leuk Res 25:511–518
Jamur MC, Oliver C (2011) Origin, maturation and recruitment of mast cell precursors. Front Biosci (Schol Ed) 3:1390–1406
Gross HJ, Verwer B, Houck D, Recktenwald D (1993) Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry 14:519–526
Gross HJ, Verwer B, Houck D et al (1995) Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(−7). Proc Natl Acad Sci U S A 92:537–541
Leary JF (1994) Strategies for rare cell detection and isolation. Methods Cell Biol 42(Pt B):331–358
Leary JF, Schmidt DF, Gram JG et al (1994) High-speed flow cytometric analysis and sorting of human fetal cells from maternal blood for molecular characterization. Ann N Y Acad Sci 731:138–141
Sánchez ML, Almeida J, Vidriales B et al (2002) Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia 16:1460–1469
Mayrhofer G, Gadd SJ, Spargo LD, Ashman LK (1987) Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. Immunol Cell Biol 65:241–250
Lerner NB, Nocka KH, Cole SR et al (1991) Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77:1876–1883
Ashman LK, Cambareri AC, To, L.B et al (1991) Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78:30–37
Orfao A, Escribano L, Villarrubia J et al (1996) Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. Am J Pathol 149:1493–1499
Escribano L, Orfao A, Díaz-Agustin B et al (1998) Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 91:2731–2736
Núñez-López R, Escribano L, Schernthaner G-H et al (2003) Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol 120:257–265
Escribano L, Orfao A, Díaz-Agustín B et al (1998) Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface. Cytometry 34:223–228
Díaz-Agustín B, Escribano L, Bravo P et al (1999) The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease. Br J Haematol 106:400–405
Teodosio C, García-Montero AC, Jara-Acevedo M et al (2010) Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 125:719–726
Alvarez-Twose I, Matito A, Sanchez-Munoz L et al (2012) Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions. Allergy 67:1190–1191
Sánchez-Muñoz L, Morgado JMT, Alvarez-Twose I et al (2013) Flow cytometry criteria for systemic mastocytosis: bone marrow mast cell counts do not always count. Am J Clin Pathol 139:404–406
Schernthaner GH, Jordan JH, Ghannadan M et al (2001) Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. Blood 98:3784–3792
Agis H, Willheim M, Sperr WR et al (1993) Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol 151:4221–4227
Agis H, Füreder W, Bankl HC et al (1996) Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 87:535–543
Rottem M, Okada T, Goff JP, Metcalfe DD (1994) Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI− cell population. Blood 84:2489–2496
Kempuraj D, Saito H, Kaneko A et al (1999) Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 93:3338–3346
Kirshenbaum AS, Goff JP, Semere T et al (1999) Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94:2333–2342
Matarraz S, López A, Barrena S et al (2008) The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors. Leukemia 22:1175–1183
Dahl C, Hoffmann HJ, Saito H, Schiøtz PO (2004) Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro. Allergy 59:1087–1096
Schernthaner G-H, Hauswirth AW, Baghestanian M et al (2005) Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors. Allergy 60:1248–1255
Tedla N, Lee C-W, Borges L et al (2008) Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells. J Leukoc Biol 83:334–343
Yokoi H, Myers A, Matsumoto K et al (2006) Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy 61:769–776
Shimizu Y, Suga T, Maeno T et al (2004) Detection of tryptase-, chymase+ cells in human CD34 bone marrow progenitors. Clin Exp Allergy 34:1719–1724
Escribano L, Orfao A, Villarrubia J et al (1998) Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples. Anal Cell Pathol 16:151–159
Escribano L, Garcia-Montero AC, Núñez R, Orfao A (2006) Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell disease. Immunol Allergy Clin N Am 26:535–547
Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135–142
Marshall JS (2004) Mast-cell responses to pathogens. Nat Rev Immunol 4:787–799
Abraham SN, St John AL (2010) Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10:440–452
Valent P, Schernthaner GH, Sperr WR et al (2001) Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev 179:74–81
Furuno T, Teshima R, Kitani S et al (1996) Surface expression of CD63 antigen (AD1 antigen) in P815 mastocytoma cells by transfected IgE receptors. Biochem Biophys Res Commun 219:740–744
Bühring HJ, Simmons PJ, Pudney M et al (1999) The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 94:2343–2356
Ghannadan M, Baghestanian M, Wimazal F et al (1998) Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 111:689–695
Frandji P, Oskéritzian C, Cacaraci F et al (1993) Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 151:6318–6328
Henz BM, Maurer M, Lippert U et al (2001) Mast cells as initiators of immunity and host defense. Exp Dermatol 10:1–10
Wong GH, Clark-Lewis I, McKimm-Breschkin JL, Schrader JW (1982) Interferon-gamma-like molecule induces Ia antigens on cultured mast cell progenitors. Proc Natl Acad Sci U S A 79:6989–6993
Woolhiser MR, Okayama Y, Gilfillan AM, Metcalfe DD (2001) IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol 31:3298–3307
Bodni RA, Sapia S, Galeano A, Kaminsky A (2003) Indolent systemic mast cell disease: immunophenotypic characterization of bone marrow mast cells by flow cytometry. J Eur Acad Dermatol Venereol 17:160–166
Escribano L, Orfao A, Villarrubia J et al (1995) Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease. Br J Haematol 91:941–943
Escribano L, Orfao A, Villarrubia J et al (1997) Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 30:98–102
Escribano L, Díaz-Agustín B, Bravo P et al (1999) Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults. Leuk Lymphoma 35:227–235
Escribano L, Díaz-Agustín B, Bellas C et al (2001) Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res 25:563–570
Escribano L, Díaz-Agustín B, Núñez R et al (2002) Abnormal expression of CD antigens in mastocytosis. Int Arch Allergy Immunol 127:127–132
Pardanani A, Kim Linger T, Reeder T et al (2004) Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients. Leuk Res 28:777–783
Escribano L, Diaz-Agustin B, López A et al (2004) Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry B Clin Cytom 58:1–8
Akin C, Escribano L, Nuñez R et al (2004) Well-differentiated systemic mastocytosis: a new disease variant with mature mast cell phenotype and lack of codon 816 c-Kit mutations. J Allergy Clin Immunol 113:S327
Akin C, Fumo G, Yavuz AS et al (2004) A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 103:3222–3225
Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L et al (2010) Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 125:1269–1278
Bonadonna P, Perbellini O, Passalacqua G et al (2009) Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 123:680–686
Escribano L, Alvarez-Twose I, Sánchez-Muñoz L et al (2009) Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 124:514–521
Lim K-H, Tefferi A, Lasho TL et al (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113:5727–5736
Valent P, Horny HP, Escribano L et al (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603–625
Valent P, Akin C, Escribano L et al (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Investig 37:435–453
Garcia-Montero AC, Jara-Acevedo M, Teodosio C et al (2006) KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108:2366–2372
Escribano L, Ocqueteau M, Almeida J et al (1998) Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymphoma 30:459–466
Gane P, Pecquet C, Crespeau H et al (1995) Flow cytometric monitoring of allergen induced basophil activation. Cytometry 19:361–365
Valent P, Majdic O, Maurer D et al (1990) Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol 91:198–203
Valent P, Bettelheim P (1992) Cell surface structures on human basophils and mast cells: biochemical and functional characterization. Adv Immunol 52:333–423
Valent P, Cerny-Reiterer S, Herrmann H et al (2010) Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells. Best Pract Res Clin Haematol 23:369–378
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Morgado, J.M., Sánchez-Muñoz, L., Teodósio, C., Mora, L.M.E. (2020). Identification and Immunophenotypic Characterization of Normal and Pathological Mast Cells. In: Gibbs, B.F., Falcone, F.H. (eds) Basophils and Mast Cells. Methods in Molecular Biology, vol 2163. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0696-4_27
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0696-4_27
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0695-7
Online ISBN: 978-1-0716-0696-4
eBook Packages: Springer Protocols